{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:30:35Z","timestamp":1789104635334,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-022-02594-6","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:02:31Z","timestamp":1655949751000},"page":"3057-3067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)"],"prefix":"10.1007","volume":"407","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-5541","authenticated-orcid":false,"given":"Miklos","family":"Acs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Gajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Zustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompiliu","family":"Piso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"issue":"6","key":"2594_CR1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","volume":"20","author":"SH Moolgavkar","year":"2019","unstructured":"Moolgavkar SH, Meza R, Turim J (2019) Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005. Cancer Causes Control 20(6):935\u2013944. https:\/\/doi.org\/10.1007\/s10552-009-9328-9","journal-title":"Cancer Causes Control"},{"issue":"11","key":"2594_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21037\/atm.2017.03.96","volume":"5","author":"J Kim","year":"2017","unstructured":"Kim J, Bhagwandin S, Labow DM (2017) Malignant peritoneal mesothelioma: a review. Ann Transl Med 5(11):236. https:\/\/doi.org\/10.21037\/atm.2017.03.96","journal-title":"Ann Transl Med"},{"issue":"6","key":"2594_CR3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/annonc\/mdr477","volume":"23","author":"C Cao","year":"2012","unstructured":"Cao C, Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P (2012) Sugarbaker PH (2012) Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol 23(6):1494\u20131498. https:\/\/doi.org\/10.1093\/annonc\/mdr477","journal-title":"Ann Oncol"},{"key":"2594_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-642-10862-4_5","volume":"189","author":"I Tischoff","year":"2011","unstructured":"Tischoff I, Neid M, Neumann V, Tannapfel A (2011) Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res 189:57\u201378. https:\/\/doi.org\/10.1007\/978-3-642-10862-4_5","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"2594_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10552-016-0838-y","volume":"28","author":"M Lehnert","year":"2017","unstructured":"Lehnert M, Kraywinkel K, Heinze E, Wiethege T, Johnen G, Fiebig J, Br\u00fcning T, Taeger D (2017) Incidence of malignant mesothelioma in Germany 2009\u20132013. Cancer Causes Control 28(2):97\u2013105. https:\/\/doi.org\/10.1007\/s10552-016-0838-y","journal-title":"Cancer Causes Control"},{"issue":"36","key":"2594_CR6","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237\u20136242. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640","journal-title":"J Clin Oncol"},{"issue":"2","key":"2594_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","volume":"64","author":"G Carteni","year":"2009","unstructured":"Carteni G, Manegold C, Garcia GM, Siena S, Zielinski CC, Amadori D, Liu Y, Blatter J, Visseren-Grul C, Stahel R (2009) Malignant peritoneal mesothelioma-results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer 64(2):211\u2013218. https:\/\/doi.org\/10.1016\/j.lungcan.2008.08.013","journal-title":"Lung Cancer"},{"issue":"6","key":"2594_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","volume":"32","author":"R Garcia-Carbonero","year":"2006","unstructured":"Garcia-Carbonero R, Paz-Ares L (2006) Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol 32(6):676\u2013681. https:\/\/doi.org\/10.1016\/j.ejso.2006.03.009","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"2594_CR9","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2011) A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer 117(9):1855\u20131863. https:\/\/doi.org\/10.1002\/cncr.25640","journal-title":"Cancer"},{"issue":"8","key":"2594_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6(8):727\u2013731. https:\/\/doi.org\/10.1007\/s10434-999-0727-7","journal-title":"Ann Surg Oncol"},{"key":"2594_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4613-1247-5_23J","volume":"15","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15:49\u201358. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23J","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2594_CR12","first-page":"518","volume":"111","author":"PA Clavien","year":"1992","unstructured":"Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111(5):518\u2013526","journal-title":"Surgery"},{"issue":"2","key":"2594_CR13","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31. https:\/\/doi.org\/10.1186\/cc5713","journal-title":"Crit Care"},{"issue":"10","key":"2594_CR14","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"issue":"7","key":"2594_CR15","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","volume":"25","author":"V Verma","year":"2018","unstructured":"Verma V, Sleightholm RL, Rusthoven CG, Koshy M, Sher DJ, Grover S, Simone CB 2nd (2018) Malignant peritoneal mesothelioma: national practice patterns, outcomes, and predictors of survival. Ann Surg Oncol 25(7):2018\u20132026. https:\/\/doi.org\/10.1245\/s10434-018-6499-1","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"2594_CR16","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21(24):4560\u20134567. https:\/\/doi.org\/10.1200\/JCO.2003.04.150","journal-title":"J Clin Oncol"},{"issue":"15","key":"2594_CR17","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M (2013) Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer 49(15):3140\u20133148. https:\/\/doi.org\/10.1016\/j.ejca.2013.05.027","journal-title":"Eur J Cancer"},{"issue":"6","key":"2594_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander Jr","year":"2013","unstructured":"Alexander HR Jr, Bartlett DL, Pingpank JF, Libutti SK, Royal R, Hughes MS, Holtzman M, Hanna N, Turner K, Beresneva T, Zhu Y (2013) Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 153(6):779\u2013786. https:\/\/doi.org\/10.1016\/j.surg.2013.01.001","journal-title":"Surgery"},{"issue":"13","key":"2594_CR19","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1245\/s10434-015-4498-z","volume":"22","author":"M Deraco","year":"2015","unstructured":"Deraco M, Cabras A, Baratti D, Kusamura S (2015) Immunohistochemical evaluation of minichromosome maintenance protein 7 (MCM7), topoisomerase IIalpha, and Ki-67 in diffuse malignant peritoneal mesothelioma patients using tissue microarray. Ann Surg Oncol 22(13):4344\u20134351. https:\/\/doi.org\/10.1245\/s10434-015-4498-z","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2594_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","volume":"1","author":"KH Antman","year":"1983","unstructured":"Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS (1983) Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol 1(6):386\u2013391. https:\/\/doi.org\/10.1200\/JCO.1983.1.6.386","journal-title":"J Clin Oncol"},{"issue":"13","key":"2594_CR21","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1245\/s10434-019-07803-z","volume":"26","author":"NL de Boer","year":"2019","unstructured":"de Boer NL, van Kooten JP, Damhuis RAM, Aerts JGJV, Verhoef C, Madsen EVE (2019) Malignant peritoneal mesothelioma: patterns of care and survival in the netherlands: a population-based study. Ann Surg Oncol 26(13):4222\u20134228. https:\/\/doi.org\/10.1245\/s10434-019-07803-z","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"2594_CR22","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1245\/s10434-017-5834-2","volume":"24","author":"YC Li","year":"2017","unstructured":"Li YC, Khashab T, Terhune J, Eckert RL, Hanna N, Burke A, Richard Alexander H (2017) Preoperative thrombocytosis predicts shortened survival in patients with malignant peritoneal mesothelioma undergoing operative cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 24(8):2259\u20132265. https:\/\/doi.org\/10.1245\/s10434-017-5834-2","journal-title":"Ann Surg Oncol"},{"key":"2594_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, Mcneish IA et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610\u2013618","journal-title":"N Engl J Med"},{"key":"2594_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cncr.25555","volume":"117","author":"S Varghese","year":"2011","unstructured":"Varghese S, Chen Z, Bartlett DL et al (2011) Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma. Cancer 117:361\u2013371","journal-title":"Cancer"},{"issue":"6","key":"2594_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","volume":"17","author":"MJ Teta","year":"2008","unstructured":"Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED (2008) US mesothelioma patterns 1973\u20132002: indicators of change and insights into background rates. Eur J Cancer Prev 17(6):525\u2013534. https:\/\/doi.org\/10.1097\/CEJ.0b013e3282f0c0a2","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"2594_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, Jayakrishnan TT, Donahue AE, Gamblin TC, Turaga KK, Johnston FM (2015) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 22(5):1686\u20131693. https:\/\/doi.org\/10.1245\/s10434-014-3978-x","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2594_CR27","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1245\/s10434-010-1080-6","volume":"17","author":"AU Blackham","year":"2010","unstructured":"Blackham AU, Shen P, Stewart JH, Russell GB, Levine EA (2010) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin. Ann Surg Oncol 17(10):2720\u20132727. https:\/\/doi.org\/10.1245\/s10434-010-1080-6","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2594_CR28","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1245\/s10434-018-6631-2","volume":"25","author":"B Malgras","year":"2018","unstructured":"Malgras B, Gayat E, Aoun O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Go\u00e9r\u00e9 D, Andre T, Pocard M (2018) Impact of combination chemotherapy in peritoneal mesothelioma hyperthermic intraperitoneal chemotherapy (HIPEC): The RENAPE Study. Ann Surg Oncol 25(11):3271\u20133279. https:\/\/doi.org\/10.1245\/s10434-018-6631-2","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2594_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.21873\/anticanres.15563","volume":"42","author":"M Acs","year":"2022","unstructured":"Acs M, Halmy L, Isgandarova S, Blaj S, Gerken M, Hormann B, Piso P (2022) Hyperthermic intraperitoneal chemotherapy with cisplatin and doxorubicin for 90 minutes versus 60 minutes after cytoreductive surgery (CRS) Does the 30-minute difference matter? A comparative study in a high volume centre. Anticancer Res 42(2):1019\u20131029","journal-title":"Anticancer Res"},{"issue":"1","key":"2594_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","volume":"7","author":"PA J\u00e4nne","year":"2005","unstructured":"J\u00e4nne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Taylor L, Ashland J, Ye Z, Monberg MJ, Obasaju CK (2005) Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer 7(1):40\u201346. https:\/\/doi.org\/10.3816\/CLC.2005.n.020","journal-title":"Clin Lung Cancer"},{"key":"2594_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","volume":"65","author":"V Kepenekian","year":"2016","unstructured":"Kepenekian V, Elias D, Passot G, Mery E, Goere D, Delroeux D, Quenet F, Ferron G, Pezet D, Guilloit JM, Meeus P, Pocard M, Bereder JM, Abboud K, Arvieux C, Brigand C, Marchal F, Classe JM, Lorimier G, De Chaisemartin C, Guyon F, Mariani P, Ortega-Deballon P, Isaac S, Maurice C, Gilly FN, Glehen O (2016) Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-institutional retrospective study. Eur J Cancer 65:69\u201379. https:\/\/doi.org\/10.1016\/j.ejca.2016.06.002","journal-title":"Eur J Cancer"},{"issue":"6","key":"2594_CR32","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","volume":"66","author":"F L\u00f3pez-R\u00edos","year":"2006","unstructured":"L\u00f3pez-R\u00edos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M (2006) Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 66(6):2970\u20132979. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3907","journal-title":"Cancer Res"},{"issue":"5","key":"2594_CR33","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","volume":"19","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Cabras AD, Deraco M (2012) Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study. Ann Surg Oncol 19(5):1416\u20131424. https:\/\/doi.org\/10.1245\/s10434-012-2237-2","journal-title":"Ann Surg Oncol"},{"issue":"9483","key":"2594_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366(9483):397\u2013408. https:\/\/doi.org\/10.1016\/S0140-6736(05)67025-0","journal-title":"Lancet"},{"issue":"1","key":"2594_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0046-8177(77)80067-1","volume":"8","author":"M Kannerstein","year":"1977","unstructured":"Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8(1):83\u201394. https:\/\/doi.org\/10.1016\/S0046-8177(77)80067-1","journal-title":"Hum Pathol"},{"issue":"5","key":"2594_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M (2013) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137(5):647\u2013667. https:\/\/doi.org\/10.5858\/arpa.2012-0214-OA","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2594_CR37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/PAT.0b013e3283631cce","volume":"45","author":"M Lee","year":"2013","unstructured":"Lee M, Alexander HR, Burke A (2013) Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy. Pathology 45(5):464\u2013473. https:\/\/doi.org\/10.1097\/PAT.0b013e3283631cce","journal-title":"Pathology"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-022-02594-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T22:35:41Z","timestamp":1669415741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-022-02594-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1007\/s00423-022-02594-6","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study includes anonymized prospectively gathered patient data. Informed consent was obtained from all participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}